GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shionogi & Co Ltd (FRA:SH0) » Definitions » Cyclically Adjusted Revenue per Share

Shionogi (FRA:SH0) Cyclically Adjusted Revenue per Share : €7.18 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Shionogi Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Shionogi's adjusted revenue per share for the three months ended in Mar. 2024 was €2.118. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €7.18 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Shionogi's average Cyclically Adjusted Revenue Growth Rate was 7.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 4.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Shionogi was 6.60% per year. The lowest was 2.40% per year. And the median was 3.65% per year.

As of today (2024-09-22), Shionogi's current stock price is €40.00. Shionogi's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €7.18. Shionogi's Cyclically Adjusted PS Ratio of today is 5.57.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shionogi was 8.40. The lowest was 4.61. And the median was 6.36.


Shionogi Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Shionogi's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shionogi Cyclically Adjusted Revenue per Share Chart

Shionogi Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.32 7.39 7.43 7.55 7.18

Shionogi Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.07 7.17 7.36 7.18 -

Competitive Comparison of Shionogi's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Shionogi's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shionogi's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shionogi's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Shionogi's Cyclically Adjusted PS Ratio falls into.



Shionogi Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shionogi's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.118/107.2000*107.2000
=2.118

Current CPI (Mar. 2024) = 107.2000.

Shionogi Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1.350 98.000 1.477
201409 1.447 98.500 1.575
201412 1.433 97.900 1.569
201503 1.711 97.900 1.874
201506 1.391 98.400 1.515
201509 1.669 98.500 1.816
201512 2.000 98.100 2.186
201603 2.022 97.900 2.214
201606 1.869 98.100 2.042
201609 2.169 98.000 2.373
201612 2.542 98.400 2.769
201703 2.106 98.100 2.301
201706 1.859 98.500 2.023
201709 2.272 98.800 2.465
201712 2.110 99.400 2.276
201803 1.947 99.200 2.104
201806 2.158 99.200 2.332
201809 1.913 99.900 2.053
201812 2.429 99.700 2.612
201903 2.623 99.700 2.820
201906 2.122 99.800 2.279
201909 2.244 100.100 2.403
201912 2.437 100.500 2.599
202003 2.170 100.300 2.319
202006 1.939 99.900 2.081
202009 1.996 99.900 2.142
202012 1.950 99.300 2.105
202103 1.854 99.900 1.989
202106 1.724 99.500 1.857
202109 1.947 100.100 2.085
202112 1.922 100.100 2.058
202203 2.933 101.100 3.110
202206 1.682 101.800 1.771
202209 1.850 103.100 1.924
202212 4.441 104.100 4.573
202303 2.097 104.400 2.153
202306 2.424 105.200 2.470
202309 2.624 106.200 2.649
202312 2.345 106.800 2.354
202403 2.118 107.200 2.118

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Shionogi  (FRA:SH0) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Shionogi's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=40.00/7.18
=5.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shionogi was 8.40. The lowest was 4.61. And the median was 6.36.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Shionogi Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Shionogi's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Shionogi Business Description

Industry
Traded in Other Exchanges
Address
1-8, Doshomachi 3-chome, Chuo-ku, Osaka, JPN, 541-0045
Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. Shionogi engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late stage drug discovery through commercial production. The company's research and development strategy utilizes partnership and licensing opportunities with academic constituents and venture companies.

Shionogi Headlines

No Headlines